Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease Diagnosis”

2,963 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,963 results

Not applicableStudy completedNCT04773015
What this trial is testing

Evaluate the Effectiveness of VIZAMYL™ Reader Training Programme in Europe

Who this might be right for
Cognitive Impairment
GE Healthcare 227
Not applicableUnknownNCT05256121
What this trial is testing

HAPPCAP-AD (Human-APPlication Combined Approach for Prevention of Alzheimer's Disease)

Who this might be right for
Alzheimer Disease
Sheba Medical Center 100
Early research (Phase 1)Looking for participantsNCT07230652
What this trial is testing

MAD Study to Evaluate the Safety and Tolerability of LY03020

Who this might be right for
SchizophreniaAlzheimer's Disease Psychosis
Luye Pharma Group Ltd. 40
Not applicableLooking for participantsNCT04956549
What this trial is testing

Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)

Who this might be right for
Dementia of Alzheimer Type
Pennington Biomedical Research Center 144
Early research (Phase 1)Study completedNCT01565343
What this trial is testing

18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 25
Not applicableStudy completedNCT00954616
What this trial is testing

Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly

Who this might be right for
Alzheimer's Disease
University Hospital, Limoges 636
Post-approval studies (Phase 4)UnknownNCT00229333
What this trial is testing

Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia

Who this might be right for
Depressive Syndrome
Sheba Medical Center 40
Not applicableNot Yet RecruitingNCT07230158
What this trial is testing

Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease II (TRANSFORM-AD II)

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT06602258
What this trial is testing

E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 105
Large-scale testing (Phase 3)Study completedNCT01872598
What this trial is testing

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AB Science 721
Not applicableStudy completedNCT01505504
What this trial is testing

Mirtazapine in Alzheimer-associated Weight Loss

Who this might be right for
Alzheimer's DiseaseWeight LossMixed Dementia+1 more
Brugmann University Hospital 22
Early research (Phase 1)Study completedNCT00714571
What this trial is testing

Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI)

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseTraumatic Brain Injury
VA Office of Research and Development 82
Not applicableStudy completedNCT05015478
What this trial is testing

Rhythmic Light Therapy for Alzheimer's Disease Patients

Who this might be right for
Mild Cognitive Impairment
Icahn School of Medicine at Mount Sinai 52
Testing effectiveness (Phase 2)Study completedNCT00501111
What this trial is testing

Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AstraZeneca 659
Not applicableStudy completedNCT00297414
What this trial is testing

An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine

Who this might be right for
Mild Cognitive Impairment
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,083
Testing effectiveness (Phase 2)Study completedNCT00151333
What this trial is testing

Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Wyeth is now a wholly owned subsidiary of Pfizer 16
Not applicableLooking for participantsNCT07031687
What this trial is testing

Effects and Mechanisms of Temporal Interference Brain Stimulation on Memory Function in Preclinical Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 1,200
Post-approval studies (Phase 4)Study completedNCT02190084
What this trial is testing

Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia

Who this might be right for
ApathyAlzheimer's Dementia
Central Arkansas Veterans Healthcare System 20
Large-scale testing (Phase 3)Ended earlyNCT04464564
What this trial is testing

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 241
Testing effectiveness (Phase 2)Study completedNCT05617508
What this trial is testing

N-DOSE AD: A Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Haukeland University Hospital 80
Load More Results